Immunotherapy has made remarkable strides in cancer therapy over the past decade.
However, such emerging therapy still suffers from the low response rates and immune …

Nanodynamic therapies that generate free radicals/reactive oxygen species (ROS) in situ
have the possibility to treat deep-seated tumors and have gradually become attractive …

How to optimize the enzyme-like catalytic activity of nanozymes to improve their applicability
has become a great challenge. Herein, we present an l-cysteine (l-Cys) coordination-driven …

Limited substrates content is a major hurdle dampening the antitumor effect of catalytic
therapy. Herein, a two-dimensional interplanar heterojunction (FeOCl/FeOOH NSs) with· OH …

The past few years have witnessed the rise of chemodynamic therapy (CDT) as an emerging
strategy for malignant tumors suppression. Nanoplatform-based CDT has great potential …

Non-invasive tumor therapy via in situ ROS generation is emerging as an appealing
treatment modality with the potential for deep-seated tumors without side effects on healthy …

Bioactive inorganic nanomaterials and the biological effects of metal ions have attracted
extensive attention in tumor therapy in recent years. Vanadium (V), as a typical bioactive …

Reactive oxygen species (ROS)-based dynamic cancer therapies are therapeutic modalities
of endogenous/exogenous-responsive intratumoral ROS generation, including …

Owing to its remarkable ease of use, ultrasound has recently been explored for stimulating
or amplifying immune responses during cancer therapy, termed 'sono-immunotherapy' …

Chemodynamic immunotherapy that utilizes catalysts to produce reactive oxygen species
(ROS) for killing tumor cells and arousing antitumor immunity has received considerable …